Role of MRI Breast in Detection of Ductal Carcinoma in Situ

Superior University

Status: Active, not recruiting

Conditions: Carcinoma in Situ

Treatments: Diagnostic Test: Magnetic Resonance Imaging (MRI)

Study type: Observational

Funder types: Other

Identifiers

NCT06744140

MSAHS/Batch-Spring23/018

Details and patient eligibility

About

"This study investigates the role of Magnetic Resonance Imaging (MRI) in detecting Ductal Carcinoma in situ (DCIS) in high-risk breast cancer patients.

Full description

Improved detection rates of DCIS in high-risk patients. Enhanced diagnostic accuracy, reducing false positives and negatives. Ductal Carcinoma in situ (DCIS) is a non-invasive breast cancer where abnormal cells are confined to the milk ducts.

The Breast Imaging Reporting and Data System (BI-RADS) is a standardized scoring system used to classify breast imaging findings. Scores range from 0 (incomplete) to 6 (known biopsy-proven malignancy)."

Enrollment: 35 patients

Sex: All

Ages: 30 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• High-risk breast cancer patients with a family history of breast cancer or genetic predispositions (e.g., BRCA mutations).
• Patients aged 30-65 years.
• Patients willing to undergo breast MRI screening for DCIS detection.

Exclusion criteria

• Patients with contraindications to MRI imaging (e.g., pacemakers, claustrophobia).
• Patients with a history of prior breast surgery or interventions that may interfere with imaging interpretation.